StockData
Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE) stock

FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$20.50+0.91 (+4.65%)

Close on Nov 18, 2026Market cap $1.98BP/E –Yield –

Fortrea operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Fortrea's operating income for the twelve months ending Sep 30, 2026 was $12.80M. For fiscal 2025 it was -$872.60M. The highest annual figure on record is $187.10M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$872.60M–
FY2024Dec 31, 2024-$161.90M-605.9%
FY2023Dec 31, 2023$32.00M-82.9%
FY2022Dec 31, 2022$187.10M+63.7%
FY2021Dec 31, 2021$114.30M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$15.00M–
Q2 FY2026Jun 30, 2026$14.80M–
Q1 FY2026Mar 31, 2026-$3.40M–
Q4 FY2025Dec 31, 2025-$13.60M–
Q3 FY2025Sep 30, 2025-$8.60M–
Q2 FY2025Jun 30, 2025-$330.30M–
Q1 FY2025Mar 31, 2025-$520.10M–
Q4 FY2024Dec 31, 2024-$55.60M–
Q3 FY2024Sep 30, 2024-$18.00M-274.8%
Q2 FY2024Jun 30, 2024-$50.90M-261.1%
Q1 FY2024Mar 31, 2024-$37.40M-365.2%
Q4 FY2023Dec 31, 2023-$24.00M-267.8%
Q3 FY2023Sep 30, 2023$10.30M-85.1%
Q2 FY2023Jun 30, 2023$31.60M-55.6%
Q1 FY2023Mar 31, 2023$14.10M–
Q4 FY2022Dec 31, 2022$14.30M–
Q3 FY2022Sep 30, 2022$68.90M–
Q2 FY2022Jun 30, 2022$71.20M–

More Fortrea figures

See a number that looks wrong?